A Non-Hallucinogenic LSD Analog With Therapeutic Potential for Mood Disorders

被引：0
|
作者：
Valles, Argel Aguilar [1 ]
Lewis, Vern [1 ]
Telfer, Andre [1 ]
Arsenault, Emily [1 ]
Taghavi-Abkuh, Fatimeh-Frouh [1 ]
El Sayegh, Fatema [1 ]
Abizaid, Alfonso [1 ]
机构：
[1] Carleton Univ, Ottawa, ON, Canada
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
LSD; Dendritic Arborization; Spine Morphogenesis; Stress Coping; 5-HT2A Receptor;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P358
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [21] ACTIVITY OF A NON-HALLUCINOGENIC ERGOLINE DERIVATIVE, LISURIDE, IN AN ANIMAL BEHAVIOR MODEL FOR HALLUCINOGENS
    MARINI, JL
    JACOBS, BL
    SHEARD, MH
    TRULSON, ME
    PSYCHOPHARMACOLOGY, 1981, 73 (04) : 328 - 331
  • [22] Non-hallucinogenic psychedelic psychotherapy: Decreasing risk and increasing access, or missing the point?
    Pashdag, Joanna
    JOURNAL OF PSYCHEDELIC STUDIES, 2025, 9 (01): : 4 - 7
  • [23] THERAPEUTIC POTENTIAL OF MOOD DISORDERS CLINICS - MUNOZ,RA
    HAIER, RJ
    CONTEMPORARY PSYCHOLOGY-APA REVIEW OF BOOKS, 1986, 31 (02): : 96 - 97
  • [24] THERAPEUTIC POTENTIAL OF MOOD DISORDERS CLINICS - MUNOZ,RA
    SHUCTER, SR
    JOURNAL OF CLINICAL PSYCHIATRY, 1985, 46 (04) : 149 - 149
  • [25] Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs
    Cunningham, Michael J.
    Bock, Hailey A.
    Serrano, Inis C.
    Bechand, Benjamin
    Vidyadhara, D. J.
    Bonniwell, Emma M.
    Lankri, David
    Duggan, Priscilla
    Nazarova, Antonina L.
    Cao, Andrew B.
    Calkins, Maggie M.
    Khirsariya, Prashant
    Hwu, Christopher
    Katritch, Vsevolod
    Chandra, Sreeganga S.
    McCorvy, John D.
    Sames, Dalibor
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (01): : 119 - 135
  • [26] Hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists induce distinct patterns of G protein coupling in postmortem human brain
    Miranda-Azpiazu, P.
    Diez-Alarcia, R.
    Garcia-Bea, A.
    Gonzalez-Maeso, J.
    Morentin, B.
    Meana, J. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S201 - S201
  • [27] Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders
    Rios, Adiel C.
    Maurya, Pawan Kumar
    Pedrini, Mariana
    Zeni-Graiff, Maiara
    Asevedo, Elson
    Mansur, Rodrigo B.
    Wieck, Andrea
    Grassi-Oliveira, Rodrigo
    McIntyre, Roger S.
    Hayashi, Mirian A. F.
    Brietzke, Elisa
    REVIEWS IN THE NEUROSCIENCES, 2017, 28 (07) : 739 - 749
  • [28] Therapeutic potential of JAK/STAT pathway modulation in mood disorders
    Shariq, Aisha S.
    Brietzke, Elisa
    Rosenblat, Joshua D.
    Pan, Zihang
    Rong, Carola
    Ragguett, Renee-Marie
    Park, Caroline
    McIntyre, Roger S.
    REVIEWS IN THE NEUROSCIENCES, 2019, 30 (01) : 1 - 7
  • [29] THE NON-HALLUCINOGENIC SEROTONIN 1B RECEPTOR IS NECESSARY FOR THE PERSISTING BEHAVIORAL EFFECTS OF PSILOCYBIN IN MICE
    Fleury, Sixtine
    Nautiyal, Kate
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 466 - 466
  • [30] Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
    Lowe, Henry
    Toyang, Ngeh
    Steele, Blair
    Grant, Justin
    Ali, Amza
    Gordon, Lorenzo
    Ngwa, Wilfred
    MOLECULES, 2022, 27 (08):
12345